The lancet oncology

• Latest
• Best
• Search…

• The lancet oncology · Jun 2013

  Comment

  Integration of general oncology and palliative care.

  no abstract available

  explore more… or not…

• The lancet oncology · Jun 2013

  Comment

  A selective ALK inhibitor in ALK-rearranged patients.

  no abstract available

  read more… or just mark as read…

• The lancet oncology · Jun 2013

  Asbestos is not just asbestos: an unrecognised health hazard.

  no abstract available

  read more… or not…

• The lancet oncology · Jun 2013

  Comment Letter

  Extending the case for oestradiol in androgen-sensitive prostate cancer.

  no abstract available

  read more… mark as read…

• The lancet oncology · Jun 2013

  Randomized Controlled Trial Multicenter Study Comparative Study

  Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.

  Definitive chemoradiotherapy (CRT) is an alternative to surgery for the curative treatment of oesophageal carcinoma. The SCOPE1 trial aimed to investigate the addition of cetuximab to cisplatin and fluoropyrimidine-based definitive CRT in patients with localised oesophageal squamous-cell cancer and adenocarcinomas to assess activity, safety, and feasibility of use. ⋯ Cancer Research UK.

  read more… or not…